Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Genome replication affects transcription factor binding mediating the cascade of herpes simplex virus transcription.

Dremel SE, DeLuca NA.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3734-3739. doi: 10.1073/pnas.1818463116. Epub 2019 Feb 11.

2.

Oligoadenylate-Synthetase-Family Protein OASL Inhibits Activity of the DNA Sensor cGAS during DNA Virus Infection to Limit Interferon Production.

Ghosh A, Shao L, Sampath P, Zhao B, Patel NV, Zhu J, Behl B, Parise RA, Beumer JH, O'Sullivan RJ, DeLuca NA, Thorne SH, Rathinam VAK, Li P, Sarkar SN.

Immunity. 2019 Jan 15;50(1):51-63.e5. doi: 10.1016/j.immuni.2018.12.013. Epub 2019 Jan 8.

PMID:
30635239
3.

Temporal Viral Genome-Protein Interactions Define Distinct Stages of Productive Herpesviral Infection.

Dembowski JA, DeLuca NA.

MBio. 2018 Jul 17;9(4). pii: e01182-18. doi: 10.1128/mBio.01182-18.

4.

Erratum for Fox et al., "A Herpesviral Immediate Early Protein Promotes Transcription Elongation of Viral Transcripts".

Fox HL, Dembowski JA, DeLuca NA.

MBio. 2018 Mar 6;9(2). pii: e00255-18. doi: 10.1128/mBio.00255-18. No abstract available.

5.

Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins.

Dembowski JA, Deluca NA.

J Vis Exp. 2017 Aug 31;(126). doi: 10.3791/56374.

6.

A Herpesviral Immediate Early Protein Promotes Transcription Elongation of Viral Transcripts.

Fox HL, Dembowski JA, DeLuca NA.

MBio. 2017 Jun 13;8(3). pii: e00745-17. doi: 10.1128/mBio.00745-17. Erratum in: MBio. 2018 Mar 6;9(2):.

7.

Replication-Coupled Recruitment of Viral and Cellular Factors to Herpes Simplex Virus Type 1 Replication Forks for the Maintenance and Expression of Viral Genomes.

Dembowski JA, Dremel SE, DeLuca NA.

PLoS Pathog. 2017 Jan 17;13(1):e1006166. doi: 10.1371/journal.ppat.1006166. eCollection 2017 Jan.

8.

Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector.

Taylor TJ, Diaz F, Colgrove RC, Bernard KA, DeLuca NA, Whelan SPJ, Knipe DM.

Virology. 2016 Sep;496:186-193. doi: 10.1016/j.virol.2016.06.006. Epub 2016 Jun 20.

9.

History and genomic sequence analysis of the herpes simplex virus 1 KOS and KOS1.1 sub-strains.

Colgrove RC, Liu X, Griffiths A, Raja P, Deluca NA, Newman RM, Coen DM, Knipe DM.

Virology. 2016 Jan;487:215-21. doi: 10.1016/j.virol.2015.09.026. Epub 2015 Nov 5. Review.

10.

Selective recruitment of nuclear factors to productively replicating herpes simplex virus genomes.

Dembowski JA, DeLuca NA.

PLoS Pathog. 2015 May 27;11(5):e1004939. doi: 10.1371/journal.ppat.1004939. eCollection 2015 May.

11.

Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells.

Harkness JM, Kader M, DeLuca NA.

J Virol. 2014 Jun;88(12):6847-61. doi: 10.1128/JVI.00516-14. Epub 2014 Apr 9.

12.

Temporal association of herpes simplex virus ICP4 with cellular complexes functioning at multiple steps in PolII transcription.

Wagner LM, DeLuca NA.

PLoS One. 2013 Oct 11;8(10):e78242. doi: 10.1371/journal.pone.0078242. eCollection 2013.

13.

Requirement of the N-terminal activation domain of herpes simplex virus ICP4 for viral gene expression.

Wagner LM, Bayer A, Deluca NA.

J Virol. 2013 Jan;87(2):1010-8. doi: 10.1128/JVI.02844-12. Epub 2012 Nov 7.

14.

Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein.

Orzalli MH, DeLuca NA, Knipe DM.

Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):E3008-17. doi: 10.1073/pnas.1211302109. Epub 2012 Oct 1.

15.

The N terminus and C terminus of herpes simplex virus 1 ICP4 cooperate to activate viral gene expression.

Wagner LM, Lester JT, Sivrich FL, DeLuca NA.

J Virol. 2012 Jun;86(12):6862-74. doi: 10.1128/JVI.00651-12. Epub 2012 Apr 11.

16.

Herpes simplex virus 1 ICP4 forms complexes with TFIID and mediator in virus-infected cells.

Lester JT, DeLuca NA.

J Virol. 2011 Jun;85(12):5733-44. doi: 10.1128/JVI.00385-11. Epub 2011 Mar 30.

17.

Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1.

Ferenczy MW, Ranayhossaini DJ, Deluca NA.

J Virol. 2011 May;85(10):4993-5002. doi: 10.1128/JVI.02265-10. Epub 2011 Mar 16.

18.

Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0.

Ferenczy MW, DeLuca NA.

J Virol. 2011 Apr;85(7):3424-35. doi: 10.1128/JVI.02263-10. Epub 2010 Dec 29.

19.

Epigenetic modulation of gene expression from quiescent herpes simplex virus genomes.

Ferenczy MW, DeLuca NA.

J Virol. 2009 Sep;83(17):8514-24. doi: 10.1128/JVI.00785-09. Epub 2009 Jun 17.

20.

Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery.

Hadjipanayis CG, Fellows-Mayle W, Deluca NA.

Mol Ther. 2008 Nov;16(11):1783-8. doi: 10.1038/mt.2008.185. Epub 2008 Aug 26.

21.

Oligomerization of ICP4 and rearrangement of heat shock proteins may be important for herpes simplex virus type 1 prereplicative site formation.

Livingston CM, DeLuca NA, Wilkinson DE, Weller SK.

J Virol. 2008 Jul;82(13):6324-36. doi: 10.1128/JVI.00455-08. Epub 2008 Apr 23.

22.

Stabilized binding of TBP to the TATA box of herpes simplex virus type 1 early (tk) and late (gC) promoters by TFIIA and ICP4.

Zabierowski SE, Deluca NA.

J Virol. 2008 Apr;82(7):3546-54. doi: 10.1128/JVI.02560-07. Epub 2008 Jan 23.

24.

Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons.

Terry-Allison T, Smith CA, DeLuca NA.

J Virol. 2007 Nov;81(22):12394-405. Epub 2007 Sep 12.

25.

DNA-dependent oligomerization of herpes simplex virus type 1 regulatory protein ICP4.

Kuddus RH, DeLuca NA.

J Virol. 2007 Sep;81(17):9230-7. Epub 2007 Jun 20.

26.

Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.

Watanabe D, Brockman MA, Ndung'u T, Mathews L, Lucas WT, Murphy CG, Felber BK, Pavlakis GN, Deluca NA, Knipe DM.

Virology. 2007 Jan 20;357(2):186-98. Epub 2006 Sep 22.

27.
28.
30.

Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery.

Niranjan A, Wolfe D, Tamura M, Soares MK, Krisky DM, Lunsford LD, Li S, Fellows-Mayle W, DeLuca NA, Cohen JB, Glorioso JC.

Mol Ther. 2003 Oct;8(4):530-42.

31.

Relationship of herpes simplex virus genome configuration to productive and persistent infections.

Jackson SA, DeLuca NA.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7871-6. Epub 2003 Jun 9.

33.
34.

Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection.

Eidson KM, Hobbs WE, Manning BJ, Carlson P, DeLuca NA.

J Virol. 2002 Mar;76(5):2180-91.

37.

Design and application of HSV vectors for neuroprotection.

Fink DJ, DeLuca NA, Yamada M, Wolfe DP, Glorioso JC.

Gene Ther. 2000 Jan;7(2):115-9. Review.

38.
39.

Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.

Brehm M, Samaniego LA, Bonneau RH, DeLuca NA, Tevethia SS.

Virology. 1999 Apr 10;256(2):258-69.

42.
46.

Interaction of the viral activator protein ICP4 with TFIID through TAF250.

Carrozza MJ, DeLuca NA.

Mol Cell Biol. 1996 Jun;16(6):3085-93.

47.

Analysis of phosphorylation sites of herpes simplex virus type 1 ICP4.

Xia K, DeLuca NA, Knipe DM.

J Virol. 1996 Feb;70(2):1061-71.

48.
49.

Gene transfer to neurons using herpes simplex virus-based vectors.

Fink DJ, DeLuca NA, Goins WF, Glorioso JC.

Annu Rev Neurosci. 1996;19:265-87. Review.

PMID:
8833444
50.

Supplemental Content

Loading ...
Support Center